ctrl K

Watchlist Price Alert

Sagimet Biosciences Inc. (SGMT)

NASDAQ: SGMT · Real-Time Price · USD

8.27

-0.34 (-3.95%)

At close: Jun 13, 2025, 3:59 PM

8.34

0.85%

After-hours: Jun 13, 2025, 07:57 PM EDT

Sagimet Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	75.84M	75.14M	158K	56.73M	68.7M	10.21M
Short-Term Investments	75.41M	19.76M	32.19M	n/a	n/a	n/a
Long-Term Investments	7.41M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	27K	27K	27K	27K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	463K	397K	34K	1.51M	36K	58K
Total Current Assets	152.77M	96.65M	32.79M	58.66M	68.74M	10.81M
Property-Plant & Equipment	77K	73K	212K	342K	194K	318K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	7.49M	73K	239K	369K	221K	345K
Total Assets	160.26M	96.72M	33.03M	59.03M	68.96M	11.16M
Account Payables	1.43M	186K	1.13M	761K	513K	1.2M
Deferred Revenue	n/a	n/a	3.96M	1.37M	1.01M	n/a
Short-Term Debt	78K	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	5K	556K	57K	240K	243K	n/a
Total Current Liabilities	4.45M	5.65M	5.28M	2.44M	1.91M	2.08M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	214.62M	214.63M	202.89M	134.19M
Total Long-Term Liabilities	n/a	n/a	214.7M	214.85M	202.96M	134.4M
Total Liabilities	4.45M	5.65M	219.98M	217.29M	204.87M	136.47M
Total Debt	78K	65K	211K	348K	210K	341K
Common Stock	3K	2K	1K	1K	1K	1K
Retained Earnings	-295.31M	-249.74M	-221.87M	-191.37M	-166.93M	-155.56M
Comprehensive Income	230K	30K	-84K	-214.63M	-202.89M	-0.00
Shareholders Equity	155.81M	91.06M	-186.95M	-158.26M	-135.91M	-125.31M
Total Investments	82.82M	19.76M	32.19M	n/a	n/a	n/a